UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | November 8, 2023 |
Accession Number: | 0001193125-23-270398 | ||||||
Submission Type: | POS AM | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | November 8, 2023 |
Accession Number: | 0001193125-23-270398 | ||||||
Submission Type: | POS AM | ||||||
|
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/25/2023 | $30.00 | Outperform → Mkt Perform | Raymond James |
8/18/2023 | $31.00 → $28.00 | Buy → Hold | Truist |
8/17/2023 | $29.00 → $27.00 | Sector Outperform → Sector Perform | Scotiabank |
8/17/2023 | $31.00 → $29.00 | Overweight → Equal Weight | Wells Fargo |
8/3/2023 | $30.00 → $28.00 | Buy → Neutral | Citigroup |
8/2/2023 | $30.00 → $28.00 | Neutral → Underweight | JP Morgan |
8/2/2023 | $29.00 → $26.00 | Outperform → Sector Perform | RBC Capital Mkts |
3/14/2023 | $31.00 → $28.00 | Overweight → Neutral | JP Morgan |
Raymond James downgraded Crestwood Equity Partners from Outperform to Mkt Perform and set a new price target of $30.00
Truist downgraded Crestwood Equity Partners from Buy to Hold and set a new price target of $28.00 from $31.00 previously
Scotiabank downgraded Crestwood Equity Partners from Sector Outperform to Sector Perform and set a new price target of $27.00 from $29.00 previously